Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Coronavirus

Ukraine Ministry of Health to Formally Register Favipiravir as a COVID-19 Treatment

TrialSite reported that in Russia, the Ministry of Health approved the generic form of Favipiravir, the Japanese generic of the […]

Ukraine Ministry of Health to Formally Register Favipiravir as a COVID-19 Treatment
5 months ago
Share

NYU Langone & NIA’s Impact Collaboratory Commence Long-Term Care COVID-19 Antibody Study

NYU Langone has just embarked on a small and targeted yet critically important pilot study. The study team now investigates new […]

NYU Langone & NIA’s Impact Collaboratory Commence Long-Term Care COVID-19 Antibody Study
5 months ago
Share

POTUS Accuses FDA of “Politics” In Vaccine-Approval Process, But FDA’s Mandate is a Political Decision to Remain The Gold Standard for Safety

On Wednesday, US President Donald Trump suggested that the recent initiative by the FDA to tighten-up COVID-19 vaccine guidelines was politically-motivated. More […]

POTUS Accuses FDA of “Politics” In Vaccine-Approval Process, But FDA’s Mandate is a Political Decision to Remain The Gold Standard for Safety
5 months ago
Share

Indonesia Secures Deal with AstraZeneca for 100 Million Doses of AZD1222 to Fight COVID-19

The nation of Indonesia, the fourth most populous worldwide, has inked a deal with AstraZeneca to buy 100 million COVID-19 […]

Indonesia Secures Deal with AstraZeneca for 100 Million Doses of AZD1222 to Fight COVID-19
5 months ago
Share

Chinese Researchers Develop & Share AI Model that Can Diagnose COVID-19 over Influenza & Pneumonia in 3 Seconds

Researchers from Tsinghua University and Wuhan-based Union Hospital (associated with Huazhong University of Science and Technology) have developed an artificial […]

Chinese Researchers Develop & Share AI Model that Can Diagnose COVID-19 over Influenza & Pneumonia in 3 Seconds
5 months ago
Share

American Lung Association Funding Investigators Targeting COVID-19 Research

As the COVID-19 pandemic reached the United States, the American Lung Association announced the COVID-19 Action Initiative, designed to accelerate […]

American Lung Association Funding Investigators Targeting COVID-19 Research
5 months ago
Share

HHS & Georgia Representatives Visit Meridian Clinical Research in Savannah, GA

Officials from the US Department of Health and Human Services (HHS) visited with leaders from Meridian Clinical Research in Savannah, GA. Following […]

HHS & Georgia Representatives Visit Meridian Clinical Research in Savannah, GA
5 months ago
Share

WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19

Washington University School of Medicine (WUSM) in St. Louis now leads a Phase 3 clinical trial, funded by the National […]

WUSM St. Louis Leads ACTIV-Adaptive Master Protocol Study Targeting Anti-Inflammatory Drugs for COVID-19
5 months ago
Share

American Society of Health-System Pharmacists Share Unfolding COVID-19 Guidelines

TrialSite shares the American Society of Health-System Pharmacists (ASHP) maintains an “Assessment of Evidence for COVID-19-Related Treatments.” Updated most recently […]

American Society of Health-System Pharmacists Share Unfolding COVID-19 Guidelines
5 months ago
Share

Chinese Vaccine Candidate BBIBP-CorV Shows Significant Promise

A vaccine targeting COVID-19 out of China called BBIBP-CorV, an inactivated SARS-CoV-2 vaccine, is safe and well-tolerated at all tested […]

Chinese Vaccine Candidate BBIBP-CorV Shows Significant Promise
5 months ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.